Reblozyl
| Reblozyl | |
|---|---|
| Term | Reblozyl |
| Short definition | Reblozyl - (pronounced) (REB-loh-zil) A drug used to treat anemia in adults with certain types of myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms who require regular red blood cell transfusions and whose anemia has not responded to or is unresponsive to an erythropoiesis-stimulating agent. Reblozyl is also used to treat anemia in adults with beta-thalassemia (an inherited blood disorder) who need regular red blood cell transfusions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Reblozyl - (pronounced) (REB-loh-zil) A drug used to treat anemia in adults with certain types of myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms who require regular red blood cell transfusions and whose anemia has not responded to or is unresponsive to an erythropoiesis-stimulating agent. Reblozyl is also used to treat anemia in adults with beta-thalassemia (an inherited blood disorder) who need regular red blood cell transfusions. It is also being studied in the treatment of other conditions. Reblozyl helps the bone marrow make more red blood cells. It's a kind of anti-anemia and a kind of recombinant fusion protein. Also called luspatercept
External links
- Medical encyclopedia article on Reblozyl
- Wikipedia's article - Reblozyl
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski